Smith & Nephew (SNN) Equity Income (2012 - 2013)

Smith & Nephew (SNN) posted quarterly Equity Income of -$1.0 million for Q1 2013, down 120.0% year-on-year from $5.0 million in Q1 2012, and down 125.0% on a QoQ basis from $4.0 million in Q4 2012.

Smith & Nephew (SNN) Equity Income (2012 - 2013) Analysis & Trends

Smith & Nephew (SNN) has reported Equity Income for 2 consecutive years, with -$1.0 million the latest figure, recorded in Q1 2013.

  • Quarterly Equity Income fell 120.0% year-over-year to -$1.0 million in Q1 2013, while the trailing twelve-month figure through Dec 2013 was -$1.0 million (changed N/A YoY) and the FY2025 annual result came in at $4.0 million, up 140.0% from the prior year.
  • Equity Income retreated to -$1.0 million in Q1 2013 per SNN's latest filing, from $4.0 million in the prior quarter.
  • Over the last five years, Equity Income for SNN reached as high as $5.0 million in Q1 2012 and fell as low as -$4.0 million in Q2 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 4.68 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2013 -1.00 Mn
Dec 31, 2012 4.00 Mn
Jun 30, 2012 -4.00 Mn
Mar 31, 2012 5.00 Mn